First Abu Dhabi Bank Sukuk US$5b Fourth Supplement

Summary by AI ^BETAClose X

First Abu Dhabi Bank P.J.S.C. issued a fourth supplement on October 22, 2025, to its base prospectus dated December 20, 2024. The supplement relates to the trust certificate issuance program by FAB Sukuk Company Limited, allowing for the issuance of up to U.S.$5,000,000,000 in aggregate face amount of trust certificates. The supplement must be read in conjunction with the original base prospectus.

Disclaimer*

First Abu Dhabi Bank P.J.S.C.

22 October 2025

First Abu Dhabi Bank P.J.S.C. (FAB)

Fourth Supplement dated 22 October 2025 to the Base Prospectus dated 20 December 2024

22 October 2025

This base prospectus supplement (the "Supplement") is supplemental to, forms part of and must be read and construed in conjunction with, the base prospectus dated 20 December 2024 (the "Base Prospectus") prepared by FAB Sukuk Company Limited (the "Trustee") and First Abu Dhabi Bank PJSC (the "Bank") in connection with the Trustee's trust certificate issuance programme (the "Programme") for the issuance of up to U.S.$5,000,000,000 in an aggregate face amount of trust certificates (the "Certificates"). Terms defined in the Base Prospectus shall, unless the context otherwise requires, have the same meaning when used in this Supplement.

The Supplement along with the Base Prospectus will also be available FAB's IR website.

http://www.rns-pdf.londonstockexchange.com/rns/4363E_1-2025-10-22.pdf

For more information, please visit https://www.bankfab.com/or FAB Investor Relations.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END